Gheuens Sarah, Chief Medical Officer at Agios Pharmaceuticals ($AGIO), sold shares on the open market 11 times over the last year, totaling about $1.15 million. Her most recent sale occurred on March 2, 2026. These $AGIO insider sales rank 4,605th among 11,678 individual insiders in our database, below the average sale value of $8.6 million and 6.4 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1187 | $28.96 | 74,406.0000 | 74,665,003 | 1.57% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 5666 | $0.00 | 5,667.0000 | 74,665,003 | 50.00% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 4000 | $0.00 | 0.0000 | 74,665,003 | 100.00% | 0.01% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Stock options (right to buy) | 52000 | $0.00 | 52,000.0000 | 74,665,003 | 9999.99% | 0.07% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Restricted stock units | 22000 | $0.00 | 22,000.0000 | 74,665,003 | 9999.99% | 0.03% |
| March 1, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Restricted stock units | 14000 | $0.00 | 14,000.0000 | 74,665,003 | 9999.99% | 0.02% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 4000 | $0.00 | 75,593.0000 | 74,665,003 | 5.59% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 4000 | $0.00 | 68,795.0000 | 74,665,003 | 6.17% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1187 | $28.96 | 67,608.0000 | 74,665,003 | 1.73% | 0.00% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 5666 | $0.00 | 73,274.0000 | 74,665,003 | 8.38% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 4000 | $0.00 | 8,000.0000 | 74,665,003 | 33.33% | 0.01% |
| March 2, 2026 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1681 | $28.96 | 71,593.0000 | 74,665,003 | 2.29% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 6000 | $0.00 | 67,727.0000 | 74,496,287,000 | 9.72% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 2932 | $27.09 | 64,795.0000 | 74,496,287,000 | 4.33% | 0.00% |
| Dec. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Performance share units | 6000 | $0.00 | 0.0000 | 74,496,287,000 | 100.00% | 0.00% |
| Nov. 11, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 2454 | $25.01 | 64,181.0000 | 74,496,287,000 | 3.98% | 0.00% |
| Nov. 11, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 2454 | $43.78 | 61,727.0000 | 74,496,287,000 | 3.82% | 0.00% |
| Nov. 11, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Stock options (right to buy) | 2454 | $0.00 | 26,130.0000 | 74,496,287,000 | 8.59% | 0.00% |
| Oct. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 200 | $25.01 | 61,927.0000 | 74,496,287,000 | 0.32% | 0.00% |
| Oct. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Stock options (right to buy) | 200 | $0.00 | 28,584.0000 | 74,496,287,000 | 0.69% | 0.00% |
| Oct. 30, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 200 | $43.81 | 61,727.0000 | 74,496,287,000 | 0.32% | 0.00% |
| Oct. 27, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Stock options (right to buy) | 3302 | $0.00 | 28,784.0000 | 74,496,287,000 | 10.29% | 0.00% |
| Oct. 27, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 3302 | $43.92 | 61,727.0000 | 74,496,287,000 | 5.08% | 0.00% |
| Oct. 27, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 3302 | $25.01 | 65,029.0000 | 74,496,287,000 | 5.35% | 0.00% |
| July 9, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 11067 | $37.93 | 62,118.0000 | 74,254,956,000 | 15.12% | 0.00% |
| July 9, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Stock options (right to buy) | 11914 | $0.00 | 32,086.0000 | 74,254,956,000 | 27.08% | 0.00% |
| July 9, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 11914 | $25.01 | 73,185.0000 | 74,254,956,000 | 19.44% | 0.00% |
| July 9, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 847 | $38.76 | 61,271.0000 | 74,254,956,000 | 1.36% | 0.00% |
| July 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 8374 | $0.00 | 8,375.0000 | 74,254,956,000 | 50.00% | 0.00% |
| July 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 4091 | $34.17 | 61,271.0000 | 74,254,956,000 | 6.26% | 0.00% |
| July 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 8374 | $0.00 | 65,362.0000 | 74,254,956,000 | 14.69% | 0.00% |
| July 1, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Gheuens Sarah | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 81,484,950 | 9999.99% | 0.03% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 6000 | $0.00 | 59,897.0000 | 74,103,192,000 | 11.13% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 2909 | $33.54 | 56,988.0000 | 74,103,192,000 | 4.86% | 0.00% |
| June 24, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Performance share units | 6000 | $0.00 | 6,000.0000 | 74,103,192,000 | 50.00% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Stock options (right to buy) | 43500 | $0.00 | 43,500.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Restricted stock units | 12000 | $0.00 | 12,000.0000 | 73,372,696,000 | 9999.99% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1681 | $35.54 | 53,897.0000 | 73,372,696,000 | 3.02% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 3833 | $0.00 | 48,235.0000 | 73,372,696,000 | 8.63% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1137 | $35.54 | 47,098.0000 | 73,372,696,000 | 2.36% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 4000 | $0.00 | 51,098.0000 | 73,372,696,000 | 8.49% | 0.00% |
| March 3, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1187 | $35.54 | 49,911.0000 | 73,372,696,000 | 2.32% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 5667 | $0.00 | 55,578.0000 | 73,372,696,000 | 11.35% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 5667 | $0.00 | 11,333.0000 | 73,372,696,000 | 33.34% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 4000 | $0.00 | 4,000.0000 | 73,372,696,000 | 50.00% | 0.00% |
| March 1, 2025 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 3833 | $0.00 | 0.0000 | 73,372,696,000 | 100.00% | 0.00% |
| July 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 8375 | $0.00 | 47,441.0000 | 73,091,490,000 | 21.44% | 0.00% |
| July 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 3705 | $43.85 | 43,736.0000 | 73,091,490,000 | 7.81% | 0.00% |
| July 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 8375 | $0.00 | 16,749.0000 | 73,091,490,000 | 33.33% | 0.00% |
| June 26, 2024 | Viridian Therapeutics, Inc.\DE | $VRDN | Gheuens Sarah | Not found | A | Stock Option (Right to Buy) | 21000 | $0.00 | 21,000.0000 | 0 | 9999.99% | 0.00% |
| March 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1293 | $32.57 | 36,415.0000 | 72,161,489,000 | 3.43% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 3834 | $0.00 | 37,708.0000 | 72,161,489,000 | 11.32% | 0.00% |
| March 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1349 | $32.57 | 39,066.0000 | 72,161,489,000 | 3.34% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 4000 | $0.00 | 40,415.0000 | 72,161,489,000 | 10.98% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Stock options (right to buy) | 60000 | $0.00 | 60,000.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 3834 | $0.00 | 3,833.0000 | 72,161,489,000 | 50.01% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 4000 | $0.00 | 8,000.0000 | 72,161,489,000 | 33.33% | 0.00% |
| March 1, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Restricted stock units | 17000 | $0.00 | 17,000.0000 | 72,161,489,000 | 9999.99% | 0.00% |
| Feb. 14, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 642 | $25.14 | 33,431.0000 | 72,161,489,000 | 1.88% | 0.00% |
| Feb. 12, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 2162 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| Feb. 12, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 2162 | $0.00 | 34,073.0000 | 72,161,489,000 | 6.78% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Performance share units | 5750 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| Jan. 20, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 5750 | $0.00 | 33,619.0000 | 72,161,489,000 | 20.63% | 0.00% |
| Jan. 24, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1708 | $21.64 | 31,911.0000 | 72,161,489,000 | 5.08% | 0.00% |
| Jan. 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 5000 | $0.00 | 29,658.0000 | 72,161,489,000 | 20.28% | 0.00% |
| Jan. 9, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1789 | $22.99 | 27,869.0000 | 72,161,489,000 | 6.03% | 0.00% |
| Jan. 5, 2024 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Performance share units | 5000 | $0.00 | 0.0000 | 72,161,489,000 | 100.00% | 0.00% |
| July 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Restricted stock units | 25124 | $0.00 | 25,124.0000 | 71,256,118 | 9999.99% | 0.04% |
| June 30, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | S | Common stock | 1707 | $28.36 | 24,159.0000 | 71,256,118 | 6.60% | 0.00% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Performance share units | 5750 | $0.00 | 5,750.0000 | 71,256,118 | 50.00% | 0.01% |
| June 28, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 5750 | $0.00 | 25,866.0000 | 71,256,118 | 28.58% | 0.01% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 3833 | $0.00 | 7,667.0000 | 71,256,118 | 33.33% | 0.01% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 3833 | $0.00 | 21,250.0000 | 71,256,118 | 22.01% | 0.01% |
| March 3, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | F | Common stock | 1134 | $25.02 | 20,116.0000 | 71,256,118 | 5.34% | 0.00% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Restricted stock units | 12000 | $0.00 | 12,000.0000 | 71,256,118 | 9999.99% | 0.02% |
| March 1, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | A | Stock options (right to buy) | 44000 | $0.00 | 44,000.0000 | 71,256,118 | 9999.99% | 0.06% |
| Feb. 10, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Common stock | 2162 | $0.00 | 17,767.0000 | 71,256,118 | 13.85% | 0.00% |
| Feb. 10, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | M | Restricted stock units | 2162 | $0.00 | 2,162.0000 | 71,256,118 | 50.00% | 0.00% |
| Feb. 14, 2023 | AGIOS PHARMACEUTICALS, INC. | $AGIO | Gheuens Sarah | Chief Medical Officer | F | Common stock | 758 | $28.44 | 17,009.0000 | 71,256,118 | 4.27% | 0.00% |